Effect of Pitavastatin Treatment on ApoB-48 and Lp-PLA2 in Patients with Metabolic Syndrome: Substudy of PROspective Comparative Clinical Study Evaluating the Efficacy and Safety of PITavastatin in Patients with Metabolic Syndrome
Hyo-Sun Lee (Lee HS), Chang Hee Jung (Jung CH), Sung Rae Kim (Kim SR), Hak Chul Jang (Jang HC), Cheol-Young Park (Park CY),
Endocrinol Metab. 2016;31(1):120-126.   Published online 2016 Mar 16     DOI: https://doi.org/10.3803/EnM.2016.31.1.120
Citations to this article as recorded by Crossref logo
A comprehensive review on the lipid and pleiotropic effects of pitavastatin
Amirhossein Sahebkar, Nasim Kiaie, Armita Mahdavi Gorabi, Massimo R. Mannarino, Vanessa Bianconi, Tannaz Jamialahmadi, Matteo Pirro, Maciej Banach
Progress in Lipid Research.2021; 84: 101127.     CrossRef
Change in ALT levels after administration of HMG-CoA reductase inhibitors to subjects with pretreatment levels three times the upper normal limit in clinical practice
Hyunah Kim, Hyeseon Lee, Tong Min Kim, So Jung Yang, Seo Yeon Baik, Seung-Hwan Lee, Jae-Hyoung Cho, Hyunyong Lee, Hyeon Woo Yim, In Young Choi, Kun-Ho Yoon, Hun-Sung Kim
Cardiovascular Therapeutics.2018; 36(3): e12324.     CrossRef
Articles inEndocrinology and Metabolismin 2016
Won-Young Lee
Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
Use of Moderate-Intensity Statins for Low-Density Lipoprotein Cholesterol Level above 190 mg/dL at Baseline in Koreans
Hun-Sung Kim, Hyeseon Lee, Sue Hyun Lee, Yoo Jin Jeong, Tong Min Kim, So Jung Yang, Sun Jung Baik, Hyunah Kim, Seung-Hwan Lee, Jae Hyoung Cho, In-Young Choi, Kun-Ho Yoon, Ju Han Kim
Basic & Clinical Pharmacology & Toxicology.2017; 121(4): 272.     CrossRef
Another statin option in HIV
Philip E Tarr, Helen Kovari
The Lancet HIV.2017; 4(7): e278.     CrossRef
Clinical benefits of pitavastatin: focus on patients with diabetes or at risk of developing diabetes
Vivencio Barrios, Carlos Escobar
Future Cardiology.2016; 12(4): 449.     CrossRef